Overview

Benefit of Placebo and Different Concentrations of Triamcinolone Acetonide in Nail Psoriasis

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This purpose of this study is to determine the lowest effective concentration of intralesional triamcinolone acetonide in the treatment of nail psoriasis.
Phase:
Phase 4
Details
Lead Sponsor:
Weill Medical College of Cornell University
Treatments:
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide